NEW BRUNSWICK — Johnson & Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus.
shughes@pressofac.com(Steve-Hughes), The Press of Atlantic City
Wed, 10/22/2014 - 6:26am
NEW BRUNSWICK — Johnson & Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus.